These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1770075)

  • 21. Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
    Curran RE; Claxton CR; Hutchison L; Harradine PJ; Martin IJ; Littlewood P
    Drug Metab Dispos; 2011 Mar; 39(3):551-7. PubMed ID: 21098647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of pH on plasma protein binding in equilibrium dialysis.
    Kochansky CJ; McMasters DR; Lu P; Koeplinger KA; Kerr HH; Shou M; Korzekwa KR
    Mol Pharm; 2008; 5(3):438-48. PubMed ID: 18345638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability, blood partition, and protein binding of a chemoprotective agent, 2-(allylthio)pyrazine.
    Han KS; Woo SJ; Koo CH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1998 Aug; 101(2):171-8. PubMed ID: 9821213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma protein binding of the experimental antitumour agent acridine-4-carboxamide in man, dog, rat and rabbit.
    Evans SM; Robertson IG; Paxton JW
    J Pharm Pharmacol; 1994 Jan; 46(1):63-7. PubMed ID: 8201529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability, blood partition and protein binding of an antifibrotic agent, oltipraz.
    Bu SC; Kim EJ; Kim SH; Kim SG; Lee MG
    Res Commun Mol Pathol Pharmacol; 2001; 109(5-6):333-44. PubMed ID: 12889516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH lability in serum during equilibrium dialysis.
    Brørs O; Jacobsen S
    Br J Clin Pharmacol; 1985 Jul; 20(1):85-8. PubMed ID: 4027141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buffer and pH effects on propranolol binding by human albumin and alpha 1-acid glycoprotein.
    Ravis WR; Parsons DL; Wang SJ
    J Pharm Pharmacol; 1988 Jul; 40(7):459-63. PubMed ID: 2904983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein binding characteristics of bumetanide.
    Walker PC; Berry NS; Edwards DJ
    Dev Pharmacol Ther; 1989; 12(1):13-8. PubMed ID: 2721330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of digitoxin and some related cardenolides to human plasma proteins.
    Lukas DS; De Martino AG
    J Clin Invest; 1969 Jun; 48(6):1041-53. PubMed ID: 5771186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pethidine binding in plasma: effects of methodological variables.
    La Rosa C; Mather LE; Morgan DJ
    Br J Clin Pharmacol; 1984 Apr; 17(4):411-5. PubMed ID: 6721987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of albumin concentration, albumin species, pH and temperature on the stereoselectively different binding of (S)-(+)- and (R)-(-)-1-methyl-5-phenyl-5-propyl-barbiturate to serum albumin.
    Büch HP; Knabe J; Krug R
    Arzneimittelforschung; 1995 Oct; 45(10):1049-53. PubMed ID: 8595055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of several loop diuretics to serum albumin and human serum from patients with renal failure and liver disease.
    Goto S; Yoshitomi H; Miyamoto A; Inoue K; Nakano M
    J Pharmacobiodyn; 1980 Dec; 3(12):667-76. PubMed ID: 7277182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing theophylline serum protein binding.
    Shaw LM; Fields L; Mayock R
    Clin Pharmacol Ther; 1982 Oct; 32(4):490-6. PubMed ID: 7116764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein binding of methohexital. Study of parameters and modulating factors using the equilibrium dialysis technique.
    Girard I; Ferry S
    J Pharm Biomed Anal; 1996 Mar; 14(5):583-91. PubMed ID: 8738188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of free concentration of piroxicam and naproxen in plasma. The influence of experimental conditions in equilibrium dialysis.
    Hundal O; Rugstad HE
    Fundam Clin Pharmacol; 1991; 5(4):275-83. PubMed ID: 1916611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The protein binding of timegadine determined by equilibrium dialysis.
    George S; McBurney A; Ward J
    Br J Clin Pharmacol; 1984 Nov; 18(5):785-90. PubMed ID: 6508987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro protein binding behavior of dipyridamole.
    MacGregor TR; Sardi ED
    J Pharm Sci; 1991 Feb; 80(2):119-20. PubMed ID: 2051312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein binding of enprofylline.
    Tegnér K; Borgå O; Svensson I
    Eur J Clin Pharmacol; 1983; 25(5):703-8. PubMed ID: 6420163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma protein binding of disopyramide by equilibrium dialysis and ultrafiltration.
    David BM; Tjokrosetio R; Ilett KF
    Ther Drug Monit; 1983; 5(1):81-6. PubMed ID: 6845403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.